BioSpace News Archive

Business

Mayo Clinic, Hitachi to Build First, Next-Generation, Carbon Ion Therapy Treatment Facility in North America

Mayo Clinic and Hitachi, Ltd. have reached an agreement in principle to build a carbon ion treatment facility as part of Mayo Clinic’s recently announced integrated oncology facility which will be constructed at Mayo Clinic’s campus in Jacksonville, Florida.

November 21, 2019
·
3 min read
Pharm Country

Gelest, Inc. Launches Offering of Novel Alkylsilicates for Drug Discovery

Gelest, Inc., an innovator in materials science, announced today the company has launched a line of novel alkylsilicates.

November 21, 2019
·
2 min read
Sanofi in Talks to Sell, Spin-Off or Create Joint Venture of its Consumer Health Unit

The company’s consumer health unit is worth about $30 billion.

November 21, 2019
·
3 min read
·
Mark Terry
Deals

BMS Completes $74 Billion Celgene Takeover

With the acquisition complete, Celgene is now a wholly-owned subsidiary of BMS. The combined companies have nine products with more than $1 billion in annual sales.

November 21, 2019
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Nov. 22

Pharma and biotech companies strengthen their leadership teams and boards with this week’s appointments.

November 21, 2019
·
5 min read
·
Alex Keown
Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website

Expedeon AG announced that it has made information available on a dedicated website relating to the transaction agreement with Abcam plc, Cambridge, UK.

November 21, 2019
·
1 min read
Business

Pelican Canada Managing Director Ed Meyer to Lead Peli BioThermal’s Global Sales Organisation in its Next Chapter of Success

Peli BioThermal, the global name in temperature-controlled packaging, announces the appointment of Ed Meyer, general manager for Canada sales and operations of parent company Pelican Products, Inc., to the global sales leadership role for the BioThermal division.

November 21, 2019
·
3 min read
Biosense Webster Launches a Two-pronged Initiative to Tackle the New Millennium Epidemic of Atrial Fibrillation

A new Atrial Fibrillation Management Report highlights that catheter ablation is almost 10 times more effective at delaying Atrial Fibrillation progression than drug therapy, yet just 4% of eligible patients are receiving ablation therapy

November 21, 2019
·
12 min read
FDA

FDA Approves Second-Ever RNA Interference Drug, Alnylam’s Givlaari

The U.S. Food and Drug Administration approved Alnylam Pharmaceuticals’ Givlaari (givosiran) for acute hepatic porphyria.

November 21, 2019
·
2 min read
·
Mark Terry
Policy

Sackler-Owned Mundipharma Uses Tactics Similar to Purdue in OxyContin Marketing in China, AP Report Shows

The AP report shows that in China, Mundipharma representatives are informing doctors that OxyContin is less addictive than other painkillers, which is a similar tactic the company used in the 1990s in the United States.

November 21, 2019
·
2 min read
·
Alex Keown